HIGHLIGHTS
- who: Yuji Iwanami and colleagues from the Department of Rehabilitation Medicine, Toho University Omori Medical Center, Omori-nishi, Ota-ku, Tokyo, Japan have published the research work: Benefits of Pulmonary Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Drug Treatment, in the Journal: (JOURNAL) of 11/09/2022
- what: The authors investigated the effect of PR with concurrent AFD administration and AFD monotherapy on 6MWD and HRQOL at 3 months. No significant change observed in this study may be attributed to the short study period of 3 months (12 weeks) compared to the 52 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.